These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25600574)

  • 41. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.
    Kristoffersen KB; Søgaard OS; Wejse C; Black FT; Greve T; Tarp B; Storgaard M; Sodemann M
    Clin Microbiol Infect; 2009 May; 15(5):481-7. PubMed ID: 19416298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock.
    Ryu JA; Yang JH; Lee D; Park CM; Suh GY; Jeon K; Cho J; Baek SY; Carriere KC; Chung CR
    PLoS One; 2015; 10(9):e0138150. PubMed ID: 26367532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
    Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
    Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration.
    Oh JS; Kim SU; Oh YM; Choe SM; Choe GH; Choe SP; Kim YM; Hong TY; Park KN
    Am J Emerg Med; 2009 Sep; 27(7):859-63. PubMed ID: 19683118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prospective study of procalcitonin as a diagnostic marker of the severity of secondary peritonitis].
    Viñas Trullen X; Rodríguez López R; Porta Pi S; Salazar Terceros D; Macarulla Sanz E; Besora Canal P; Alvarez Tellez F; Iglesias Castro C; Feliu Palá X
    Cir Esp; 2009 Jul; 86(1):24-8. PubMed ID: 19481200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
    Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
    PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.
    Layios N; Lambermont B; Canivet JL; Morimont P; Preiser JC; Garweg C; Ledoux D; Frippiat F; Piret S; Giot JB; Wiesen P; Meuris C; Massion P; Leonard P; Nys M; Lancellotti P; Chapelle JP; Damas P
    Crit Care Med; 2012 Aug; 40(8):2304-9. PubMed ID: 22809906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
    Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Procalcitonin rapid test in surgical patients treated in the intensive care unit].
    Pinkola K; Darvas K
    Magy Seb; 2001 Dec; 54(6):368-70. PubMed ID: 11816134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procalcitonin as a prognostic marker in meningococcal disease.
    Van der Kaay DC; De Kleijn ED; De Rijke YB; Hop WC; De Groot R; Hazelzet JA
    Intensive Care Med; 2002 Nov; 28(11):1606-12. PubMed ID: 12415448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.
    Clec'h C; Fosse JP; Karoubi P; Vincent F; Chouahi I; Hamza L; Cupa M; Cohen Y
    Crit Care Med; 2006 Jan; 34(1):102-7. PubMed ID: 16374163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic change of procalcitonin, rather than concentration itself, is predictive of survival in septic shock patients when beyond 10 ng/mL.
    Guan J; Lin Z; Lue H
    Shock; 2011 Dec; 36(6):570-4. PubMed ID: 21937947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic value of lipopolysaccharide binding protein and procalcitonin in patients with severe sepsis and septic shock admitted to intensive care].
    García de Guadiana-Romualdo LM; Rebollo-Acebes S; Esteban-Torrella P; Jiménez-Sánchez R; Hernando-Holgado A; Ortín-Freire A; Viqueira-González M; Trujillo-Santos J; Jiménez Santos E; Pedregosa Díaz J; Albaladejo-Otón MD; Allegue-Gallego JM
    Med Intensiva; 2015 May; 39(4):207-12. PubMed ID: 24953001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction in procalcitonin level and outcome in critically ill children with severe sepsis/septic shock-A pilot study.
    Poddar B; Gurjar M; Singh S; Aggarwal A; Baronia A
    J Crit Care; 2016 Dec; 36():230-233. PubMed ID: 27566963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?
    Svoboda P; Kantorová I; Scheer P; Radvanova J; Radvan M
    Hepatogastroenterology; 2007 Mar; 54(74):359-63. PubMed ID: 17523274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is Interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults.
    Weidhase L; Wellhöfer D; Schulze G; Kaiser T; Drogies T; Wurst U; Petros S
    BMC Infect Dis; 2019 Feb; 19(1):150. PubMed ID: 30760225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study.
    Rau BM; Frigerio I; Büchler MW; Wegscheider K; Bassi C; Puolakkainen PA; Beger HG; Schilling MK
    Arch Surg; 2007 Feb; 142(2):134-42. PubMed ID: 17309964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical research of timing of application of antibiotics in septic shock of pediatric patients].
    Wang XD; Huo XM; Xu MX; Geng WJ; Guo YM; Cao LJ; Sun H; Shi XN; Li JE; Shi HY; Li P; Kang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Apr; 25(4):207-10. PubMed ID: 23660095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
    Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.